Publisher
Springer International Publishing
Reference25 articles.
1. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs. 1976;22:80–93.
2. Khaja W, Bilen O, Lukner R, Edwards R, Teruya J. Evaluation of heparin assay for coagulation management in newborns on ECMO. Am J Clin Pathol. 2010;134:950–4.
3. O’Meara LC, Alten JA, Goldberg KG, Timpa JG, Phillips J, Laney D, Borasino S. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation. ASAIO J. 2015;61:339–44. https://doi.org/10.1097/MAT.0000000000000204.
4. Yie K, Chon SD, Na CY. Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR). Perfusion. 2016;31:307–15. pii:0267659115604710
5. Brodin E, Svenesson B, Paulssen RH, Nordoy A, Hansen JB. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment. J Lab Clin Med. 2004;144:246–53.